Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Perrigo : Completes Generic Rx Pharmaceuticals Business Sale For $1.55 Billion

07/06/2021 | 04:48pm EDT


© MT Newswires 2021
All news about PERRIGO COMPANY PLC
09/09PERRIGO : HABSONT UNLIMITED COMPANY (Form 8-K)
PU
09/09PERRIGO CO PLC : Entry into a Material Definitive Agreement, Financial Statement..
AQ
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
09/08INDIAN MORNING BRIEFING : Asian Markets Lower After Wall Street Decline
DJ
09/08Sherwin-Williams, PulteGroup fall; Perrigo, Kadmon rise
AQ
09/08Health Care Flat On Defensive Bias -- Health Care Roundup
DJ
09/08US Stocks End Lower as Economic Recovery Concerns Continue
MT
09/08Wall Street ends lower, weighed down by Big Tech
RE
09/08Health Care Stocks Edging Lower Just Ahead of Wednesday Close
MT
09/08PERRIGO : to Buy Consumer Self-Care Company Hera for $2.1 Billion; Shares Rise
MT
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2021 4 189 M - -
Net income 2021 - - -
Net Debt 2021 1 515 M - -
P/E ratio 2021 -40,3x
Yield 2021 2,26%
Capitalization 5 921 M 5 921 M -
EV / Sales 2021 1,78x
EV / Sales 2022 2,13x
Nbr of Employees 11 500
Free-Float 98,8%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 44,28 $
Average target price 51,00 $
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Raymond P. Silcock CFO, Principal Accounting Officer & Executive VP
Rolf Allan Classon Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-0.98%5 921
JOHNSON & JOHNSON4.98%435 465
ROCHE HOLDING AG11.23%327 497
PFIZER, INC.21.62%251 011
NOVO NORDISK A/S49.16%231 607
ELI LILLY AND COMPANY36.84%211 895